Maintaining quality has always been imperative for the healthcare industry to protect the safety of patients and consumers. It is rare to see discussion of future of pharmaceutical manufacturing without using the terms Quality by Design (QbD) and Process Analytical Technologies (PAT).
PAT & Qbd goes hand in hand with each other.. It has been seen with the adoption of QbD and PAT principles for a new product development makes sense not only from the regulatory compliance perspective, but also make sense for financial reasons. They certainly complement each-other and the likelihood is that the partnership has a very promising future. This workshop will focus on discussing the existing challenges and explore practical applications related to drug development, manufacturing and regulatory. It’s a 2-day program which will include presentations, talks, case studies, panel discussions from industry leaders, solution providers and academia.